Christopher Galletta, Controller and Principal Accounting Officer at Trevi Therapeutics, holds 26.09K shares in Trevi Therapeutics (Ticker: TRVI), holds 500.00 shares in Transact Technologies (Ticker: TACT).
What is the percentage of profitable transactions made by Christopher Galletta?
The percentage of profitable transactions made by Christopher Galletta is 67%.
What is the average return per transaction made by Christopher Galletta?
The average return per transaction made by Christopher Galletta is 20.50%.
What stocks does Christopher Galletta hold?
Christopher Galletta holds: TRVI, TACT stocks.
What was Christopher Galletta’s latest transaction?
Christopher Galletta latest transaction was an Uninformative Buy of $2.15K.
What was Christopher Galletta's most profitable transaction?
Christopher Galletta’s most profitable transaction was an Informative Sell of TACT stock on May 12, 2011. The return on the trade was 37.90%.
What is Christopher Galletta's role in Trevi Therapeutics?
Christopher Galletta's role in Trevi Therapeutics is Controller and Principal Accounting Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.